Cancer stem cells are the main cause of tumor recurrence and resistance to treatment [32], and CD44 is the most commonly used molecular marker for identifying TNBC stem cells and numerous studies have demonstrated that the expression of CD44 is associated with tumor grade, tumor recurrence, and metastasis in breast cancer patients [7, 33]. Here, CD44 is linked to breast carcinoma.